|
AP1019A
(en)
|
1996-10-18 |
2001-10-16 |
Vertex Pharma |
Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
|
|
US7491794B2
(en)
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
|
US10086511B2
(en)
|
2003-11-10 |
2018-10-02 |
Brooks Automation, Inc. |
Semiconductor manufacturing systems
|
|
US8696298B2
(en)
*
|
2003-11-10 |
2014-04-15 |
Brooks Automation, Inc. |
Semiconductor manufacturing process modules
|
|
WO2005087721A2
(en)
*
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
Compounds as inhibitors of hepatitis c virus ns3 serine protease
|
|
US7635694B2
(en)
*
|
2004-02-27 |
2009-12-22 |
Schering Corporation |
Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
|
|
WO2006130554A2
(en)
*
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods of treating hepatitis c virus
|
|
US20060275366A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Controlled-release formulation
|
|
NZ563365A
(en)
*
|
2005-06-02 |
2011-02-25 |
Schering Corp |
Combination of HCV protease inhibitors with a surfactant
|
|
US20060281689A1
(en)
*
|
2005-06-02 |
2006-12-14 |
Schering Corporation |
Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
|
|
JP2008545748A
(ja)
*
|
2005-06-02 |
2008-12-18 |
シェーリング コーポレイション |
Ｃ型肝炎ウイルスに関連する障害を処置するために有用な徐放処方物
|
|
WO2006130552A2
(en)
*
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods of treating hepatitis c virus
|
|
US20070237818A1
(en)
*
|
2005-06-02 |
2007-10-11 |
Malcolm Bruce A |
Controlled-release formulation of HCV protease inhibitor and methods using the same
|
|
US20070021351A1
(en)
*
|
2005-06-02 |
2007-01-25 |
Schering Corporation |
Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor
|
|
US20060276404A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Anima Ghosal |
Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
|
|
NZ563361A
(en)
|
2005-06-02 |
2011-02-25 |
Schering Corp |
HCV protease inhibitors in combination with food
|
|
AU2006276246B2
(en)
*
|
2005-07-25 |
2012-09-27 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis C virus replication
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
ES2356776T3
(es)
|
2005-10-11 |
2011-04-13 |
Intermune, Inc. |
Compuestos y métodos para inhibir la replicación del virus de la hepatitis.
|
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
|
EP2392589A3
(en)
|
2005-11-11 |
2012-06-20 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
RU2008144294A
(ru)
*
|
2006-04-11 |
2010-05-20 |
Новартис АГ (CH) |
Ингибиторы вируса гепатита с (hcv)
|
|
US20080045530A1
(en)
*
|
2006-04-11 |
2008-02-21 |
Trixi Brandl |
Organic Compounds and Their Uses
|
|
AU2007249668B2
(en)
|
2006-04-11 |
2011-04-07 |
Novartis Ag |
HCV/HIV inhibitors and their uses
|
|
RU2008152171A
(ru)
|
2006-07-05 |
2010-08-10 |
Интермьюн, Инк. (Us) |
Новые ингибиторы вирусной репликации гепатита с
|
|
RU2009109355A
(ru)
|
2006-08-17 |
2010-09-27 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Ингибиторы вырусной полимеразы
|
|
US20100081672A1
(en)
*
|
2006-12-07 |
2010-04-01 |
Schering Corporation |
Ph sensitive matrix formulation
|
|
US20080219810A1
(en)
*
|
2007-03-05 |
2008-09-11 |
Van Der Meulen Peter |
Semiconductor manufacturing process modules
|
|
EP2139854A2
(en)
*
|
2007-03-23 |
2010-01-06 |
Schering Corporation |
P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
|
|
US20100104534A1
(en)
*
|
2007-03-23 |
2010-04-29 |
Srikanth Venkatraman |
Hydrazido-peptides as inhibitors of hcv ns3-protease
|
|
SG174809A1
(en)
*
|
2007-05-03 |
2011-10-28 |
Intermune Inc |
Macrocyclic compounds useful as inhibitors of hepatitis c virus
|
|
JP2010526834A
(ja)
|
2007-05-10 |
2010-08-05 |
インターミューン・インコーポレーテッド |
Ｃ型肝炎ウイルス複製の新規ペプチド阻害剤
|
|
US8242140B2
(en)
|
2007-08-03 |
2012-08-14 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
CN101868452B
(zh)
|
2007-10-10 |
2014-08-06 |
诺华股份有限公司 |
螺环吡咯烷类与其对抗hcv和hiv感染的应用
|
|
US8419332B2
(en)
*
|
2007-10-19 |
2013-04-16 |
Atlas Bolt & Screw Company Llc |
Non-dimpling fastener
|
|
EP2234977A4
(en)
|
2007-12-19 |
2011-04-13 |
Boehringer Ingelheim Int |
VIRAL POLYMERASE INHIBITORS
|
|
ES2437147T3
(es)
|
2008-02-04 |
2014-01-09 |
Idenix Pharmaceuticals, Inc. |
Inhibidores de serina proteasa macrocíclicos
|
|
WO2009142842A2
(en)
|
2008-04-15 |
2009-11-26 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
|
CN102271699A
(zh)
|
2009-01-07 |
2011-12-07 |
西尼克斯公司 |
用于治疗hcv和hiv感染的环孢菌素衍生物
|
|
US8102720B2
(en)
*
|
2009-02-02 |
2012-01-24 |
Qualcomm Incorporated |
System and method of pulse generation
|
|
AR075584A1
(es)
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
|
EP2403860B1
(en)
|
2009-03-04 |
2015-11-04 |
IDENIX Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole as hcv polymerase inhibitors
|
|
TW201040181A
(en)
|
2009-04-08 |
2010-11-16 |
Idenix Pharmaceuticals Inc |
Macrocyclic serine protease inhibitors
|
|
US20110182850A1
(en)
*
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
|
CA2763140A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
|
EP2461811B1
(en)
|
2009-08-05 |
2016-04-20 |
Idenix Pharmaceuticals LLC. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
|
US20110117055A1
(en)
|
2009-11-19 |
2011-05-19 |
Macdonald James E |
Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
|
|
JP2013512246A
(ja)
|
2009-11-25 |
2013-04-11 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
|
|
KR20120118008A
(ko)
|
2009-12-18 |
2012-10-25 |
아이데닉스 파마슈티칼스, 인코포레이티드 |
5,5-융합 아릴렌 또는 헤테로아릴렌 간염 ｃ 바이러스 억제제
|
|
US20130156731A1
(en)
|
2009-12-22 |
2013-06-20 |
Kevin X. Chen |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
|
|
EA201290882A1
(ru)
|
2010-03-09 |
2013-04-30 |
Мерк Шарп Энд Домэ Корп. |
Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
|
|
WO2012018534A2
(en)
|
2010-07-26 |
2012-02-09 |
Schering Corporation |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
|
JP5565320B2
(ja)
*
|
2011-01-06 |
2014-08-06 |
富士通株式会社 |
情報処理装置及び情報処理プログラム
|
|
AR085352A1
(es)
|
2011-02-10 |
2013-09-25 |
Idenix Pharmaceuticals Inc |
Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
|
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
|
WO2012142075A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2012158861A2
(en)
*
|
2011-05-18 |
2012-11-22 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
|
|
WO2013033899A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2013033900A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2013033901A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
|
US20140378416A1
(en)
|
2011-09-14 |
2014-12-25 |
Michael P. Dwyer |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
EP3046924A1
(en)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
WO2015065817A1
(en)
|
2013-10-30 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
|
US20170135990A1
(en)
|
2014-03-05 |
2017-05-18 |
Idenix Pharmaceuticals Llc |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
|
CN104292130B
(zh)
*
|
2014-10-13 |
2016-04-27 |
苏州永健生物医药有限公司 |
一种波普瑞韦中间体2-羟基-3-氨基-4-环丁基丁酰胺盐酸盐的合成方法
|
|
CA3189027A1
(en)
|
2020-07-11 |
2022-01-20 |
Pfizer Inc. |
Antiviral heteroaryl ketone derivatives
|
|
US11351149B2
(en)
|
2020-09-03 |
2022-06-07 |
Pfizer Inc. |
Nitrile-containing antiviral compounds
|
|
CN117836272B
(zh)
*
|
2021-08-02 |
2025-02-28 |
北京华益健康药物研究中心 |
用于治疗或预防冠状病毒感染的3cl蛋白酶小分子抑制剂及其用途
|